Do reductions in brain N-acetylaspartate levels contribute to the etiology of some neuropsychiatric disorders?

Journal of Neuroscience Research

Volumn 91, Issue 7, 2013, Pages 934-942

  Ariyannur, Prasanth S ^a   Arun, Peethambaran ^a   Barry, Erin S ^b   Andrews Shigaki, Brian ^b   Bosomtwi, Asamoah ^a   Tang, Haiying ^a   Selwyn, Reed ^a   Grunberg, Neil E ^b   Moffett, John R ^a   Namboodiri, Aryan M A ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

Dopamine; HPLC; Locomotor activity; Magnetic resonance spectroscopy; Methamphetamine; N acetylaspartylglutamate; NAA; NAAG

Indexed keywords

METHAMPHETAMINE; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BRAIN; BRAIN CORTEX; CEREBELLUM; FOREBRAIN; GENE DELETION; HETEROZYGOSITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHALAMUS; KNOCKOUT MOUSE; LOCOMOTION; MALE; MENTAL DISEASE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OPEN FIELD TEST; PHENOTYPE; PRIORITY JOURNAL; WILD TYPE;

ACETYLTRANSFERASES; ANALYSIS OF VARIANCE; ANIMALS; ASPARTIC ACID; BRAIN; CHOLINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIPEPTIDES; DOPAMINE AGENTS; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; LOCOMOTION; MAGNETIC RESONANCE SPECTROSCOPY; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 84877923070     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23234     Document Type: Article

References (42)

1. Ariyannur PS, Moffett JR, Madhavarao CN, Arun P, Vishnu N, Jacobowitz D, Hallows WC, Denu JM, Namboodiri AM. 2010a. Nuclear-cytoplasmic localization of acetyl coenzyme A synthetase-1 in the rat brain. J Comp Neurol 518:2952-2977.
2. Ariyannur PS, Moffett JR, Manickam P, Pattabiraman N, Arun P, Nitta A, Nabeshima T, Madhavarao CN, Namboodiri AM. 2010b. Methamphetamine-induced neuronal protein NAT8L is the NAA biosynthetic enzyme: implications for specialized acetyl coenzyme A metabolism in the CNS. Brain Res 1335:1-13.
3. Arun P, Madhavarao CN, Moffett JR, Namboodiri AM. 2006. Regulation of N-acetylaspartate and N-acetylaspartylglutamate biosynthesis by protein kinase activators. J Neurochem 98:2034-2042.
4. Arun P, Madhavarao CN, Moffett JR, Namboodiri AM. 2008. Antipsychotic drugs increase N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cells. J Neurochem 106:1669-1680.
5. Arun P, Moffett JR, Namboodiri AM. 2009. Evidence for mitochondrial and cytoplasmic N-acetylaspartate synthesis in SH-SY5Y neuroblastoma cells. Neurochem Int 55:219-225.
6. Arun P, Madhavarao CN, Moffett JR, Hamilton K, Grunberg NE, Ariyannur PS, Gahl WA, Anikster Y, Mog S, Hallows WC, Denu JM, Namboodiri AM. 2010. Metabolic acetate therapy improves phenotype in the tremor rat model of Canavan disease. J Inherit Metab Dis 33:195-210.
7. Aydin K, Uysal S, Yakut A, Emiroglu B, Yilmaz F. 2011. N-acetylaspartate concentration in corpus callosum is positively correlated with intelligence in adolescents. Neuroimage 59:1058-1064.
8. Baslow MH. 2002. Evidence supporting a role for N-acetyl-L-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review. Neurochem Int 40:295-300.
9. Baslow MH. 2003. Brain N-acetylaspartate as a molecular water pump and its role in the etiology of Canavan disease: a mechanistic explanation. J Mol Neurosci 21:185-190.
10. Becker I, Lodder J, Gieselmann V, Eckhardt M. 2010. Molecular characterization of N-acetylaspartylglutamate synthetase. J Biol Chem 285:29156-29164.
11. Benarroch EE. 2008. N-acetylaspartate and N-acetylaspartylglutamate: neurobiology and clinical significance. Neurology 70:1353-1357.
12. Bertolino A, Knable MB, Saunders RC, Callicott JH, Kolachana B, Mattay VS, Bachevalier J, Frank JA, Egan M, Weinberger DR. 1999. The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia. Biol Psychiatry 45:660-667.
13. Bertolino A, Breier A, Callicott JH, Adler C, Mattay VS, Shapiro M, Frank JA, Pickar D, Weinberger DR. 2000. The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia. Neuropsychopharmacology 22:125-132.
14. Bottomley PA. 1987. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 508:333-348.
15. Brugger S, Davis JM, Leucht S, Stone JM. 2011. Proton magnetic resonance spectroscopy and illness stage in schizophrenia-a systematic review and meta-analysis. Biol Psychiatry 69:495-503.
16. Burlina AP, Schmitt B, Engelke U, Wevers RA, Burlina AB, Boltshauser E. 2006. Hypoacetylaspartia: clinical and biochemical follow-up of a patient. In: Moffett JR, Tieman SB, Weinberger DR, Coyle JT, Namboodiri MA, editors. N-acetylaspartate: a unique neuronal molecule in the central nervous system. New York: Springer Science and Business Media. p 283-287.
17. Chakraborty G, Mekala P, Yahya D, Wu G, Ledeen RW. 2001. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J Neurochem 78:736-745.
18. Clark JB. 1998. N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev Neurosci 20:271-276.
19. Clark JF, Doepke A, Filosa JA, Wardle RL, Lu A, Meeker TJ, Pyne-Geithman GJ. 2006. N-acetylaspartate as a reservoir for glutamate. Med Hypoth 67:506-512.
20. Collard F, Stroobant V, Lamosa P, Kapanda CN, Lambert DM, Muccioli GG, Poupaert JH, Opperdoes F, Van Schaftingen E. 2010. Molecular identification of N-acetylaspartylglutamate synthase and beta-citrylglutamate synthase. J Biol Chem 285:29826-29833.
21. Furukawa-Hibi Y, Nitta A, Fukumitsu H, Somiya H, Toriumi K, Furukawa S, Nabeshima T, Yamada K. 2012. Absence of SHATI/Nat8l reduces social interaction in mice. Neurosci Lett 526:79-84.
22. Gehl LM, Saab OH, Bzdega T, Wroblewska B, Neale JH. 2004. Biosynthesis of NAAG by an enzyme-mediated process in rat central nervous system neurons and glia. J Neurochem 90:989-997.
23. Grachev ID, Kumar R, Ramachandran TS, Szeverenyi NM. 2001. Cognitive interference is associated with neuronal marker N-acetyl aspartate in the anterior cingulate cortex: an in vivo 1H-MRS study of the Stroop Color-Word task. Mol Psychiatry 6:496-539.
24. Grippo AJ, Beltz TG, Johnson AK. 2003. Behavioral and cardiovascular changes in the chronic mild stress model of depression. Physiol Behav 78:703-710.
25. Jones NC, Cardamone L, Williams JP, Salzberg MR, Myers D, O'Brien TJ. 2008. Experimental traumatic brain injury induces a pervasive hyperanxious phenotype in rats. J Neurotrauma 25:1367-1374.
26. Jung RE, Gasparovic C, Chavez RS, Caprihan A, Barrow R, Yeo RA. 2009. Imaging intelligence with proton magnetic resonance spectroscopy. Intelligence 37:192-198.
27. Maddock RJ, Buonocore MH. 2012. MR spectroscopic studies of the brain in psychiatric disorders. Curr Top Behav Neurosci [e-pub ahead of print].
28. Madhavarao CN, Arun P, Moffett JR, Szucs S, Surendran S, Matalon R, Garbern J, Hristova D, Johnson A, Jiang W, Namboodiri MA. 2005. Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. Proc Natl Acad Sci U S A 102:5221-5226.
29. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM. 2007. N-ascetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 81:89-131.
30. Neale JH, Bzdega T, Wroblewska B. 2000. N-acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J Neurochem 75:443-452.
31. Niwa M, Nitta A, Mizoguchi H, Ito Y, Noda Y, Nagai T, Nabeshima T. 2007. A novel molecule "shati" is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference. J Neurosci 27:7604-7615.
32. Niwa M, Nitta A, Cen X, Kitaichi K, Ozaki N, Yamada K, Nabeshima T. 2008a. A novel molecule "shati" increases dopamine uptake via the induction of tumor necrosis factor-alpha in pheochromocytoma-12 cells. J Neurochem 107:1697-1708.
33. Niwa M, Yan Y, Nabeshima T. 2008b. Genes and molecules that can potentiate or attenuate psychostimulant dependence: relevance of data from animal models to human addiction. Ann N Y Acad Sci 1141:76-95.
34. Patel TB, Clark JB. 1979. Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem J 184:539-546.
35. Prut L, Belzung C. 2003. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3-33.
36. Reynolds LM, Reynolds GP. 2011. Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorder. J Psychiatr Res 45:54-59.
37. Ryman SG, Gasparovic C, Bedrick EJ, Flores RA, Marshall AN, Jung RE. 2011. Brain biochemistry and personality: a magnetic resonance spectroscopy study. PLoS ONE 6:e26758.
38. Sarkisova KY, Kulikov MA, Midzyanovskaya IS, Folomkina AA. 2008. Dopamine-dependent nature of depression-like behavior in WAG/Rij rats with genetic absence epilepsy. Neurosci Behav Physiol 38:119-128.
39. Tsai G, Coyle JT. 1995. N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol 46:531-540.
40. Wang J, Leone P, Wu G, Francis JS, Li H, Jain MR, Serikawa T, Ledeen RW. 2009. Myelin lipid abnormalities in the aspartoacylase-deficient tremor rat. Neurochem Res 34:138-148.
41. Wiame E, Tyteca D, Pierrot N, Collard F, Amyere M, Noel G, Desmedt J, Nassogne MC, Vikkula M, Octave JN, Vincent MF, Courtoy PJ, Boltshauser E, Van Schaftingen E. 2010. Molecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartia. Biochem J 425:127-136.
42. Zuo D, Bzdega T, Olszewski RT, Moffett JR, Neale JH. 2012. Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in the prefrontal cortex and nucleus accumbens in the phencyclidine model of schizophrenia. J Biol Chem 287:21773-21782.